Post-Operative Complications in Patients on Immune Checkpoint Inhibitors Undergoing Mohs Micrographic Surgery

Abstract

Keywords

cancer surgery wound dermatology

Get full access to this article

View all access options for this article.

References

Morelli

Fujita

Redelman-Sidi

Elkington

. Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy. Thorax. 2022;77(3):304-311.doi:10.1136/thoraxjnl-2021-217260

34607905

Mays

AC.

Yarlagadda

Achim

et al. Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer. Head Neck. 2021;43(5):1509-1520.doi:10.1002/hed.26601

33417293

Elias

AW.

Kasi

PM.

Stauffer

et al. The feasibility and safety of surgery in patients receiving immune checkpoint inhibitors: a retrospective study. Front Oncol. 2017;7:121. doi:10.3389/fonc.2017.00121

28660171

Puza

CJ.

Bressler

ES.

Terando

et al. The emerging role of surgery for patients with advanced melanoma treated with immunotherapy. J Surg Res. 2019;236:209-215.doi:10.1016/j.jss.2018.11.045

30694757

Sun

Kirichenko

DA.

Chung

et al. Perioperative outcomes of melanoma patients undergoing surgery after receiving immunotherapy or targeted therapy. World J Surg. 2020;44(4):1283-1293.doi:10.1007/s00268-019-05314-2

31811340